Advisory Resource Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
15,154
+651
| +4% | +$44.9K | 0.2% | 111 |
|
|
2025
Q1 | $1.01M | Buy |
14,503
+2,518
| +21% | +$175K | 0.21% | 101 |
|
|
2024
Q4 | $1.03M | Buy |
11,985
+4,544
| +61% | +$391K | 0.22% | 97 |
|
|
2024
Q3 | $886K | Sell |
7,441
-27
| -0.4% | -$3.22K | 0.19% | 108 |
|
|
2024
Q2 | $1.07M | Buy |
7,468
+151
| +2% | +$21.6K | 0.24% | 79 |
|
|
2024
Q1 | $940K | Buy |
7,317
+823
| +13% | +$106K | 0.22% | 83 |
|
|
2023
Q4 | $672K | Sell |
6,494
-489
| -7% | -$50.6K | 0.17% | 105 |
|
|
2023
Q3 | $635K | Buy |
6,983
+27
| +0.4% | +$2.46K | 0.17% | 95 |
|
|
2023
Q2 | $563K | Sell |
6,956
-650
| -9% | -$52.6K | 0.15% | 104 |
|
|
2023
Q1 | $605K | Sell |
7,606
-674
| -8% | -$53.6K | 0.17% | 93 |
|
|
2022
Q4 | $560K | Buy |
+8,280
| New | +$560K | 0.17% | 79 |
|
|
2022
Q3 | – | Sell |
-4,312
| Closed | -$240K | – | 140 |
|
|
2022
Q2 | $240K | Sell |
4,312
-868
| -17% | -$48.3K | 0.08% | 117 |
|
|
2022
Q1 | $288K | Buy |
5,180
+398
| +8% | +$22.1K | 0.09% | 113 |
|
|
2021
Q4 | $239K | Buy |
4,782
+572
| +14% | +$28.6K | 0.08% | 129 |
|
|
2021
Q3 | $202K | Sell |
4,210
-596
| -12% | -$28.6K | 0.07% | 133 |
|
|
2021
Q2 | $201K | Buy |
+4,806
| New | +$201K | 0.08% | 129 |
|